NEW YORK (360Dx) – Avista Capital Partners today announced a definitive agreement to buy anatomic pathology laboratory Miraca Life Sciences.

A new holding company called Symphony Buyer has been formed to become the new owner of MLS, which currently is a wholly owned subsidiary of Japanese holding firm Miraca Holdings. The basic enterprise value of the deal is approximately $175.6 million, Miraca Holdings said, adding it will own 15 percent of Symphony Buyer's shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.